Tosoh Bioscience Sustainability Profile
Tosoh Bioscience, a leading name in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe, Asia, and North America. Founded in 2003, the company has established itself as a key player in the development and manufacturing of high-quality chromatography products and bioprocessing solutions. With a focus on innovative technologies, Tosoh Bioscience offers a diverse range of core products, including affinity chromatography resins and analytical instruments, which are renowned for their reliability and performance. The company’s commitment to quality and customer satisfaction has solidified its market position, making it a trusted partner for laboratories and biopharmaceutical manufacturers worldwide. Notable achievements include significant advancements in protein purification and a robust portfolio that supports the evolving needs of the life sciences industry.
DitchCarbon Score
How does Tosoh Bioscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tosoh Bioscience's score of 35 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tosoh Bioscience's reported carbon emissions
In 2022, Tosoh Bioscience Ltd reported total carbon emissions of approximately 114,909 kg CO2e, with emissions distributed across various scopes: 24,891 kg CO2e from Scope 1, 677 kg CO2e from Scope 2, and a significant 89,341 kg CO2e from Scope 3. The Scope 3 emissions included 3,505 kg CO2e from business travel, 3,532 kg CO2e from employee commuting, and 67,780 kg CO2e from upstream transportation and distribution. Tosoh Bioscience has set an ambitious commitment to achieve net zero emissions by 2045, aiming for a reduction of about 90% across all scopes. This long-term target reflects the company's dedication to addressing climate change and reducing its carbon footprint. The emissions data is not cascaded from any parent organization, indicating that these figures are independently reported by Tosoh Bioscience. The company continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 316,972 | 0,000,000,000 |
| Scope 2 | 4,459 | 000,000,000 |
| Scope 3 | 47,681 | 0,000,000,000 |
How Carbon Intensive is Tosoh Bioscience's Industry?
How Carbon Intensive is Tosoh Bioscience's Location?
Tosoh Bioscience's Scope 3 Categories Breakdown
Tosoh Bioscience's Scope 3 emissions, which increased significantly last year and increased significantly since 2021, demonstrating supply chain emissions tracking. A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 35% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 60% of Scope 3 emissions.
Top Scope 3 Categories
Tosoh Bioscience's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tosoh Bioscience has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
